About biostar pharmaceuticals inc - BSPM
BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. Its products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting the Chinese population. The company was founded on March 27, 2007 and is headquartered in Xianyang, China.
BSPM At a Glance
BioStar Pharmaceuticals, Inc.
No. 588 Shiji Xi Avenue
Xianyang, Shaanxi 712046
| Phone | 86-29-33686638 | Revenue | 2.38M | |
| Industry | Pharmaceuticals: Major | Net Income | -5,698,385.00 | |
| Sector | Health Technology | Employees | 200 | |
| Fiscal Year-end | 12 / 2017 | |||
| View SEC Filings |
BSPM Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.823 |
| Price to Book Ratio | 0.21 |
| Price to Cash Flow Ratio | 1.37 |
| Enterprise Value to EBITDA | -3.668 |
| Enterprise Value to Sales | 3.726 |
| Total Debt to Enterprise Value | 0.262 |
BSPM Efficiency
| Revenue/Employee | 11,922.46 |
| Income Per Employee | -28,491.925 |
| Receivables Turnover | 0.348 |
| Total Asset Turnover | 0.051 |
BSPM Liquidity
| Current Ratio | 1.31 |
| Quick Ratio | 1.28 |
| Cash Ratio | 0.031 |
BSPM Profitability
| Gross Margin | 38.38 |
| Operating Margin | -149.477 |
| Pretax Margin | -127.714 |
| Net Margin | -238.977 |
| Return on Assets | -12.142 |
| Return on Equity | -14.045 |
| Return on Total Capital | -14.535 |
| Return on Invested Capital | -14.045 |
BSPM Capital Structure
| Total Debt to Total Equity | 6.306 |
| Total Debt to Total Capital | 5.932 |
| Total Debt to Total Assets | 5.472 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |